SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 42 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $15,925,009 | +3.9% | 9,007,000 | 0.0% | 0.05% | 0.0% |
Q2 2023 | $15,327,332 | -12.2% | 9,007,000 | 0.0% | 0.05% | -14.8% |
Q1 2023 | $17,447,371 | +3.8% | 9,007,000 | 0.0% | 0.05% | -5.3% |
Q4 2022 | $16,802,227 | +12.2% | 9,007,000 | 0.0% | 0.06% | -5.0% |
Q3 2022 | $14,980,000 | -30.4% | 9,007,000 | -47.0% | 0.06% | -34.1% |
Q2 2022 | $21,534,000 | -3.7% | 17,007,000 | 0.0% | 0.09% | +2.2% |
Q1 2022 | $22,352,000 | +60.3% | 17,007,000 | +78.9% | 0.09% | +58.9% |
Q4 2021 | $13,948,000 | – | 9,507,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DLD Asset Management, LP | 10,370,000 | $18,432,675 | 1.98% |
Worth Venture Partners, LLC | 1,431,000 | $2,536,677 | 1.50% |
CSS LLC/IL | 8,197,000 | $14,535,142 | 0.95% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 5,198,000 | $9,252,647 | 0.20% |
Warberg Asset Management LLC | 517,000 | $911,580 | 0.18% |
BOOTHBAY FUND MANAGEMENT, LLC | 3,889,000 | $6,893,877 | 0.16% |
PALISADE CAPITAL MANAGEMENT, LP | 1,000,000 | $1,765,625 | 0.05% |
Point72 Asset Management, L.P. | 9,007,000 | $15,925,009 | 0.05% |
CAPSTONE INVESTMENT ADVISORS, LLC | 5,082,000 | $8,984,976 | 0.04% |
D. E. Shaw & Co., Inc. | 11,089,000 | $19,645,113 | 0.02% |